One of the recalls reported last week includes a holster whose design can change the safety switch, potentially endangering the user and any bystanders.
The U.S. Consumer Product Safety Commission reported last week that Blackhawk is recalling its T-Series L2C gun holsters, which can switch the safety position without the user knowing. If the trigger is pulled, the gun could fire unexpectedly, the commission said.
No incidents or injuries have been reported.
The holsters were sold at Bass Pros Shops and other sporting goods stores nationwide and online on Blackhawk’s website from June to August.
Consumers should stop using the recalled holsters and contact Blackhawk at 888-343-7547 for a full refund.
The U.S. Food and Drug Administration also announced a number of ranitidine drug recalls last week associated with N-nitrosodimethylamine, or NDMA, which is classified as a probable human carcinogen. The impurity is a known environmental contaminant found in water and foods, including meats dairy products and vegetables, according to the FDA.
Among the ranitidine medicines included in the recall are Zantac over-the-counter medicines. The recall affects Zantac 150, Zantac 150 Cool Mint and Zantac 75. The tablets are an oral, over-the-counter product to prevent and relieve heartburn.
The Oct. 18 recall comes after the FDA issued a public statement on Sept. 13 alerting consumers about some ranitidine medicines, including Zantac, possibly containing NDMA at low levels. The FDA at the time asked manufacturers to conduct testing. Sanofi said that due to inconsistencies in preliminary test results of the active ingredient used in U.S. products, it made the decision to conduct a voluntary recall as the investigation continues.
Perrigo Co. is also voluntarily recalling its ranitidine over-the-counter medicine. The company also began testing after the FDA’s announcement and halted shipments on Oct. 8 based upon preliminary results.
Dr. Reddy’s Laboratories last week also confirmed a recall of all its ranitidine medications sold nationally, including at Dr. Reddy’s, Kroger and Walgreens. Affected products have an expiration date between September 2019 and June 2021. For NDC numbers on the product label, check out the FDA’s website at www.fda.gov.
Novitium Pharma LLC is also recalling all quantities and lots of Ranitidine Hydrochloride capsules because of the NDMA concerns. The capsules from this company were sold in 30, 60, 100 and 500-count bottles, available by prescription. For NDC numbers, check out the FDA’s website.
Another drug being recalled is from Mylan Pharmaceuticals, this time over concerns regarding a foreign substance.
The company is recalling its Alprazolam tablets, 0.5 mg, which may have foreign material. Despite the voluntary recall, the company said clinical impact from foreign material would be rare, though there is a remote risk of infection to the patient. No adverse events have been reported, associated with the recall.
The tablets are used for management of anxiety disorder and the treatment of panic disorder.
The tablets were packaged in bottles of 500 and distributed between July and August with an expiration date of September 2020 and lot number 8082708.
Consumers who have purchased the drug should contact Stericycle at 1-888-843-0255 for the documentation packet to return the product.
Email Naomi Creason at email@example.com or follow her on Twitter @SentinelCreason
Be the first to know
Get local news delivered to your inbox!